{
    "clinical_study": {
        "@rank": "38530", 
        "arm_group": [
            {
                "arm_group_label": "Mulungu", 
                "arm_group_type": "Active Comparator", 
                "description": "500 mg Mulungu Matusa\u00ae (Erytrina mulungu, 2 capsules of 250 mg) administered v.o., one hour before the surgical procedure."
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "500 mg of starch (2 capsules of 250 mg) administered v.o., one hour before the surgical procedure."
            }
        ], 
        "brief_summary": {
            "textblock": "This study evaluated the effectiveness of the Erythrina mulungu in controlling anxiety in\n      patients undergoing bilateral extraction of asymptomatic, impacted mandibular third molars."
        }, 
        "brief_title": "Anxiety Control by Erythrina Mulungu", 
        "completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Dental Anxiety", 
            "Impacted Third Molar Tooth"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Anxiety Disorders", 
                "Tooth, Impacted"
            ]
        }, 
        "detailed_description": {
            "textblock": ": In this research, characterized as a randomized, double-blind, crossover study, 30 healthy\n      volunteered patients (05 men and 25 women) aged 18 or older who received a capsule of 500mg\n      of Mulungu Matusa \u00ae or placebo, orally, one hour before the procedure were selected. The\n      level of anxiety was assessed through questionnaires and physical parameters, such as blood\n      pressure, heart rate and oxygen concentration. Data were collected, tabulated and analyzed\n      by the following statistical tests: chi-square, t-test, ANOVA and Tukey test, Friedman,\n      Fisher's exact test with significance level of 5%."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  indication of bilateral extraction of asymptomatic, impacted mandibular third molars\n\n        Exclusion Criteria:\n\n          -  patients under the age of 18\n\n          -  any general health problem based on the medical history and physical examination\n\n          -  history of use of any medication within 15 days before the beginning of the research\n\n          -  history of hypersensitivity to drugs, substances or materials used in this experiment\n\n          -  pregnancy or lactation\n\n          -  history of pericoronitis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "35 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01948622", 
            "org_study_id": "Mulungu-401-2011"
        }, 
        "intervention": [
            {
                "arm_group_label": "Mulungu", 
                "description": "500 mg/single dose/1 hour before dental surgery", 
                "intervention_name": "Mulungu", 
                "intervention_type": "Drug", 
                "other_name": "Mulungu Matusa, Erytrina mulungu"
            }, 
            {
                "arm_group_label": "placebo", 
                "description": "500 mg/single dose/1 hour before dental surgery", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Anxiety", 
            "Third molar surgery", 
            "Blood pressure", 
            "Heart rate", 
            "Oxygen saturation"
        ], 
        "lastchanged_date": "September 18, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Aracaju", 
                    "country": "Brazil", 
                    "state": "Sergipe", 
                    "zip": "49060-100"
                }, 
                "name": "Federal University of Sergipe"
            }
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Anxiety Control by Using Erythrina Mulungu in Mandibular Third Molars Extraction", 
        "overall_official": {
            "affiliation": "Federal University of Sergipe", 
            "last_name": "Liane M Souza, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Brazil: National Committee of Ethics in Research", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Changes in the  subjects' anxiety level was observed by using a Modified Corah Dental Anxiety Scale in three times: at baseline, in the day of surgery and after 7 days of the procedure.", 
            "measure": "Changes in anxiety report", 
            "safety_issue": "No", 
            "time_frame": "Change from baseline to 7 days"
        }, 
        "reference": [
            {
                "PMID": "19441926", 
                "citation": "Balbani AP, Silva DH, Montovani JC. Patents of drugs extracted from Brazilian medicinal plants. Expert Opin Ther Pat. 2009 Apr;19(4):461-73. doi: 10.1517/13543770902824180. Review."
            }, 
            {
                "PMID": "17268084", 
                "citation": "Flausino OA Jr, Pereira AM, da Silva Bolzani V, Nunes-de-Souza RL. Effects of erythrinian alkaloids isolated from Erythrina mulungu (Papilionaceae) in mice submitted to animal models of anxiety. Biol Pharm Bull. 2007 Feb;30(2):375-8."
            }, 
            {
                "PMID": "17253849", 
                "citation": "Flausino O Jr, Santos Lde A, Verli H, Pereira AM, Bolzani Vda S, Nunes-de-Souza RL. Anxiolytic effects of erythrinian alkaloids from Erythrina mulungu. J Nat Prod. 2007 Jan;70(1):48-53."
            }, 
            {
                "PMID": "14600397", 
                "citation": "Onusic GM, Nogueira RL, Pereira AM, Flausino J\u00fanior OA, Viana Mde B. Effects of chronic treatment with a water-alcohol extract from Erythrina mulungu on anxiety-related responses in rats. Biol Pharm Bull. 2003 Nov;26(11):1538-42."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01948622"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universidade Federal de Sergipe", 
            "investigator_full_name": "Liane Maciel de Almeida Souza", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "blood pressure (mmHg) was measured before drug administration, 30 minutes after drug administration and during local anesthesia, incision, tooth removal and suturing.", 
                "measure": "Changes in blood pressure", 
                "safety_issue": "Yes", 
                "time_frame": "Change from baseline to 2 hours"
            }, 
            {
                "description": "heart rate (bpm) was measured before drug administration, 30 minutes after drug administration and during local anesthesia, incision, tooth removal and suturing.", 
                "measure": "Changes in heart rate", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to 2 hours"
            }, 
            {
                "description": "oxygen saturation (SpO2) was measured before drug administration, 30 minutes after drug administration and during local anesthesia, incision, tooth removal and suturing.", 
                "measure": "Changes in oxygen saturation", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to 2 hours"
            }
        ], 
        "source": "Universidade Federal de Sergipe", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Campinas, Brazil", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Liane Maciel de Almeida Souza", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}